Investors Research Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $157K | Hold |
846
| – | – | 0.03% | 333 |
|
2025
Q1 | $177K | Buy |
846
+105
| +14% | +$22K | 0.04% | 307 |
|
2024
Q4 | $132K | Hold |
741
| – | – | 0.03% | 355 |
|
2024
Q3 | $146K | Hold |
741
| – | – | 0.03% | 348 |
|
2024
Q2 | $127K | Hold |
741
| – | – | 0.03% | 373 |
|
2024
Q1 | $135K | Sell |
741
-1,233
| -62% | -$225K | 0.03% | 367 |
|
2023
Q4 | $306K | Hold |
1,974
| – | – | 0.07% | 274 |
|
2023
Q3 | $294K | Hold |
1,974
| – | – | 0.08% | 272 |
|
2023
Q2 | $266K | Buy |
1,974
+17
| +0.9% | +$2.29K | 0.07% | 293 |
|
2023
Q1 | $312K | Hold |
1,957
| – | – | 0.08% | 270 |
|
2022
Q4 | $316K | Hold |
1,957
| – | – | 0.09% | 263 |
|
2022
Q3 | $263K | Buy |
1,957
+22
| +1% | +$2.96K | 0.08% | 270 |
|
2022
Q2 | $296K | Buy |
1,935
+287
| +17% | +$43.9K | 0.09% | 259 |
|
2022
Q1 | $267K | Sell |
1,648
-13,487
| -89% | -$2.19M | 0.08% | 281 |
|
2021
Q4 | $2.05M | Hold |
15,135
| – | – | 0.62% | 39 |
|
2021
Q3 | $1.63M | Hold |
15,135
| – | – | 0.55% | 46 |
|
2021
Q2 | $1.71M | Buy |
15,135
+59
| +0.4% | +$6.65K | 0.59% | 38 |
|
2021
Q1 | $1.63M | Sell |
15,076
-275
| -2% | -$29.8K | 0.61% | 22 |
|
2020
Q4 | $1.65M | Sell |
15,351
-100
| -0.6% | -$10.7K | 0.65% | 17 |
|
2020
Q3 | $1.35M | Sell |
15,451
-300
| -2% | -$26.3K | 0.66% | 19 |
|
2020
Q2 | $1.55M | Buy |
15,751
+98
| +0.6% | +$9.62K | 0.78% | 14 |
|
2020
Q1 | $1.19M | Sell |
15,653
-50
| -0.3% | -$3.81K | 0.74% | 12 |
|
2019
Q4 | $1.39M | Sell |
15,703
-25
| -0.2% | -$2.21K | 0.64% | 17 |
|
2019
Q3 | $1.19M | Sell |
15,728
-150
| -0.9% | -$11.4K | 0.6% | 23 |
|
2019
Q2 | $1.16M | Buy |
15,878
+13,825
| +673% | +$1.01M | 0.6% | 27 |
|
2019
Q1 | $165K | Buy |
+2,053
| New | +$165K | 0.09% | 294 |
|